Central Pharmaceutical JSC No. 3
HHNX:DP361,900.00
VND
-100.00
(-0.16%)
ISIN
VN000000DP36
Return %
Stock
S&P 500
1Y
19.27
14.20
3Y
0.32
81.12
5Y
33.41
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Khai Dinh Nguyen
- Full Time Employees
- 225
- Sector
- Health technology
- Industry
- Pharmaceuticals: other
- Address
- Haiphong Vietnam
- IPO Date
- Jul 17, 2015
- Website
- duocphamtw3.com
- Similar Companies
- Business
- Central Pharmaceutical Joint Stock Company No. 3 (Foripharm, HNX: DP3) is a Vietnam-based pharmaceutical manufacturing and trading enterprise primarily engaged in the research, development, production, and distribution of traditional herbal remedies, modern allopathic pharmaceuticals, health supplements, and medical care products. Founded in 1962 as Central Pharmaceutical Enterprise No. 3 under the Ministry of Health and converted into a joint-stock company in 2003, the company is headquartered in Hai Phong, Vietnam. Foripharm operates through three principal business divisions: Traditional Herbal Medicine, Modern Pharmaceuticals and Dietary Supplements, and Contract Manufacturing Services. Its comprehensive product portfolio comprises herbal tonics and botanical medications, led by its flagship male vitality and renal health formulation Sam Nhung Bo Than TW3; respiratory remedies, including Bo Phe TW3 Chi Khai Lo cough syrup and lozenges, as well as Siro Vihodan; cerebral and cardiovascular circulatory products, including Hoat Huyet Thong Mach TW3; traditional multi-herb medicinal pills such as Thap Toan Dai Bo, Quy Ty, and Bo Than Am; topical formulations and medicated balms, prominently featuring the legacy Golden Star Balm (Cao Sao Vang); modern pharmaceuticals spanning vitamins, antibiotics, and analgesics, including Ceteco Neurovit Fort; women's health and wellness supplements, including Lady Gold TW3; and general health supplements, including Censamin. In addition to finished dosage manufacturing, the company offers full-service contract manufacturing (OEM/ODM) solutions, encompassing custom formulation, raw material sourcing, regulatory compliance, testing, and automated packaging. Foripharm distributes its products nationwide through an extensive network of independent pharmacies, retail drugstore chains, and medical institutions across Northern, Central, and Southern Vietnam, while maintaining export channels to international markets including Russia, Ukraine, and Kazakhstan. Manufacturing operations are conducted across its facilities in Hai Phong, including the Nam Son manufacturing complex and the Trang Due Industrial Park production plant, both operating in compliance with Good Manufacturing Practice (GMP-WHO), Good Laboratory Practice (GLP), and Good Storage Practice (GSP) standards. In recent company developments, Foripharm has scaled commercial production at its Trang Due facility to expand capacity for non-sterile liquid dosage forms, dietary supplements, and cosmetic preparations; broadened its contract manufacturing business to capture expanding demand from domestic consumer healthcare brands; revitalized international export distribution and cross-border e-commerce availability for its heritage Golden Star Balm brand; and reinforced its financial position with substantial liquid reserve management while executing consecutive high cash dividend distributions approved at its recent annual general meetings.